Institute of Chemical Sciences, University of Peshawar, Peshawar, 25120, Khyber Pakhtunkhwa, Pakistan.
Department of Biological Sciences, Regional University of Cariri, CEP63105-000, Crato, Ceara, Campus Pimenta, Brazil.
Diabetes Metab Syndr. 2023 Apr;17(4):102760. doi: 10.1016/j.dsx.2023.102760. Epub 2023 Apr 9.
In the present study the research output of the South Asian region (India, Pakistan, Bangladesh, Sri Lanka, Nepal, Maldives, and Bhutan) in endocrinology, diabetes and metabolism (EDM) is highlighted. It was compared with five scientifically advanced countries i.e. USA, UK, Italy, Japan and China.
On September 13, 2022, the data was retrieved from the Scopus database. The analysis focused on the number of publications, total citations (TC), citations per paper (CPP), field-weighted citations impact (FWCI), and degree of international collaboration.
In South Asia, India produced the highest number of publications (n = 7048), followed by Pakistan (n = 799), Bangladesh (n = 345), Sri Lanka (n = 256), Nepal (n = 144), Maldives (n = 12) and Bhutan (n = 4). The highest CPP (n = 19.4) and FWCI (n = 1.18) was recorded for Sri Lanka. Furthermore, USA (n = 64022), China (n = 23991), UK (n = 21449), Italy (n = 18884), and Japan (n = 12875), published the highest number of documents with the highest citations and FWCI in the world. It was noted that India published the highest number of documents (n = 47.28%) in the quartiles (Q) 6 and Q7. Pakistan produced the highest number of documents (n = 64.22%) in the top 50% of journals (Q1 to Q5). South Asian countries produced 8332 publications, with 130382 TC, 15.6 CPP and 1.06 FWCI. Importantly 46.50% of documents from South Asian countries were published in Q6 and Q7 journals. In contrast USA, UK, Italy, Japan and China published 77% documents in top 50% journals.
Although the South Asian research publications have increased yearly (from 2012 to 2021), but approximately 50% of the South Asian output were in the lower quartile journals. Consequently, significant measures are needed to improve the quantity and quality of EDM research produced in South Asian coutries.
本研究重点介绍了南亚地区(印度、巴基斯坦、孟加拉国、斯里兰卡、尼泊尔、马尔代夫和不丹)在内分泌、糖尿病和代谢领域(EDM)的研究成果,并将其与美国、英国、意大利、日本和中国这五个科学先进国家进行了比较。
2022 年 9 月 13 日,从 Scopus 数据库中检索数据。分析重点关注出版物数量、总引文数(TC)、每篇论文的引文数(CPP)、领域加权引文影响力(FWCI)和国际合作程度。
在南亚地区,印度发表的论文数量最多(n=7048),其次是巴基斯坦(n=799)、孟加拉国(n=345)、斯里兰卡(n=256)、尼泊尔(n=144)、马尔代夫(n=12)和不丹(n=4)。斯里兰卡的 CPP(n=19.4)和 FWCI(n=1.18)最高。此外,美国(n=64022)、中国(n=23991)、英国(n=21449)、意大利(n=18884)和日本(n=12875)发表的论文数量最多,引文数量和 FWCI 也最高。值得注意的是,印度发表的论文数量(n=47.28%)在四分位区间(Q)6 和 Q7 中最多。巴基斯坦发表的论文数量(n=64.22%)在 Q1 到 Q5 的前 50%期刊中最多。南亚国家发表了 8332 篇论文,总引文数为 130382,CPP 为 15.6,FWCI 为 1.06。重要的是,南亚国家 46.50%的论文发表在 Q6 和 Q7 期刊上。相比之下,美国、英国、意大利、日本和中国在 top 50%的期刊上发表了 77%的论文。
尽管南亚地区的研究出版物数量逐年增加(2012 年至 2021 年),但大约 50%的南亚产出都在较低的四分位区间期刊上。因此,需要采取重大措施来提高南亚国家 EDM 研究的数量和质量。